Fine Mark National Bank & Trust Illumina, Inc. Transaction History

Fine Mark National Bank & Trust

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$405.61 - $524.84 $173,601 - $224,631	-428 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$372.84 - $481.5 $706,531 - $912,442	-1,895 Reduced 81.58%	428 $203,000
Q4 2020 Feb 10, 2021	BUY	$292.7 - $370.96 $679,942 - $861,740	2,323 New	2,323 $860,000

899

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Fine Mark National Bank & Trust with notifications on news.